Opus Genetics (IRD) Return on Equity [ROE] (2009 - 2026)
Opus Genetics' Return on Equity [ROE] came in at -465.32% for Q4 2025, down 184.84 percentage points from -280.48% a year earlier but up 116.62 percentage points from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Opus Genetics' Return on Equity [ROE] was -449.36%, down 246.17 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last three years, though with a four-year change of +845.74 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was -203.19% in FY2024 (-182.41 pp), -20.77% in FY2023 (-73.03 pp), 52.26% in FY2022 (+1347.36 pp) and -1295.10% in FY2021.
- The five-year range for quarterly Return on Equity [ROE] is -993.81% (Q1 2025) to 65.35% (Q3 2023).
- Year-over-year, Return on Equity [ROE] has declined for nine consecutive quarters, with an average year-over-year change of -336.68 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 326.55 percentage points), and the weakest in Q1 2025 (a drop of 970.26 percentage points).
- Business Quant data shows IRD's Return on Equity [ROE] at -581.94% (Q3 2025), -516.94% (Q2 2025) and -993.81% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Opus Genetics | 405.23 Mn | 122.33 Mn | - | -1,065.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,065.40% |
| Dec 31, 2025 | -465.32% |
| Sep 30, 2025 | -581.94% |
| Jun 30, 2025 | -516.94% |
| Mar 31, 2025 | -993.81% |
| Dec 31, 2024 | -280.48% |
| Sep 30, 2024 | -72.57% |
| Jun 30, 2024 | -32.54% |
| Mar 31, 2024 | -23.55% |
| Dec 31, 2023 | -19.93% |
| Sep 30, 2023 | 65.35% |
| Jun 30, 2023 | 47.26% |
| Mar 31, 2023 | 42.73% |
| Dec 31, 2022 | 61.56% |
| Sep 30, 2022 | -168.98% |
| Jun 30, 2022 | -138.48% |
| Mar 31, 2022 | -122.93% |
| Dec 31, 2021 | -264.99% |
| Sep 30, 2021 | -320.32% |
| Jun 30, 2021 | -408.28% |
API Access
Opus Genetics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();